This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.
Donald A. Johnson, PhD, RAC
Advertisement
Donald A. Johnson, PhD, RAC is senior scientific advisor at Eurofins BioPharma Product Testing.
Articles by Donald A. Johnson, PhD, RAC
Advertisement
Latest Updated Articles
Quantitative Rupture Testing of Soft Gelatin Capsules: Understanding Aberrant ResultsPublished: February 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
Standardizing Operations to Meet Global Sustainability and Resilience Goals
5
